Shigetaka Suekane

9PUBLICATIONS
46CO-AUTHORS
Pacific Peoples social determinants of healthEpidemiological modellingCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsBasic pharmacology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 28, 2026
Validation of the 7-Item Quality of Life Disease-Specific Impact Scale in Patients Undergoing Radical Cystectomy for Bladder Cancer: A Cross-Sectional Study.

Sayaka Shimizu, Takahiro Osawa, Miho Sato

|Jul 15, 2024
Effects of long-term desmopressin treatment for nocturia in older people.

Hirofumi Kurose, Kosuke Ueda, Katsuaki Chikui

|Dec 26, 2023
GnRH antagonist monotherapy versus a GnRH agonist plus bicalutamide for advanced hormone-sensitive prostate cancer; KYUCOG-1401.

Akira Yokomizo, Masaki Shiota, Futoshi Morokuma

|Dec 07, 2023
TAS0313 plus Pembrolizumab for Post-Chemotherapy Immune Checkpoint Inhibitor-Naïve Locally Advanced or Metastatic Urothelial Carcinoma.

Hiroyuki Nishiyama, Junji Yonese, Takashi Kawahara

|Feb 09, 2023
Determining the optimal initial dose for Japanese patients with nocturnal polyuria using an initial dose of desmopressin 50 μg.

Hirofumi Kurose, Keisuke Komiya, Naoyuki Ogasawara

|Apr 29, 2022
Radiotherapy plus androgen deprivation therapy for prostate-specific antigen persistence in lymph node-positive prostate cancer.

Masaki Shiota, Dai Takamatsu, Takahiro Kimura

Pageof 2

Frequent Collaborators

2 joint publications

Shigeru Yutani

2 joint publications

Masanori Noguchi

2 joint publications

Akira Yokomizo

2 joint publications

Makoto Nakiri